Prevalence and associated Factors of Anxiety among Type 2 Diabetes Mellitus Patients on Follow Up at Ambo General Hospital, Oromia Regional State, Ethiopia, Institutional Based Cross Sectional Study

Abstract

Anxiety has been shown to be associated with poor outcomes in people with diabetes. However, there has been limited data, especially from Ethiopia, which has specifically examined whether diabetes mellitus is associated with an increased likelihood of co morbid anxiety. Objective To assess the prevalence and associated factors of Anxiety among patients with type 2 diabetes mellitus on follow up at Ambo general hospital, Oromia Regional State, Ethiopia.

Dulaglutide For effective diabetes management

“…Dulaglutide has been approved by the US FDA and the EMA for the management of hyperglycemia in T2DM and 0.75 mg to 1.5 mg once-weekly dose have demonstrated Haemoglobin A1c reduction of ∼0.7%-1.6% as monotherapy and in combination (dual or triple therapy) in controlled clinical trials [9,10]. The glucose-lowering activity with dulaglutide involves both postprandial plasma glucose concentrations, with low hypoglycaemia risk and reductions of fasting.…”